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E-mail: abdou.padane@iressef.orgFIG. 1. Distribution of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) lineages in Senegal.In late December 2019, cases of pneumonia of unknown aeti-
ology were reported by Chinese authorities in the city of
Wuhan, China [1]. In January 2020, the World Health Orga-
nization declared an international public health emergency. The
pathogen was identified as severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), and the disease was named
coronavirus disease 2019 (COVID-19) [2]. Africa was last to
report SARS-CoV-2 infections [3]. Egypt was the first African
country to record a case of COVID-19, 7 weeks after the start
of the pandemic [4,5]. As of this writing (2 March 2021), Africa
has recorded 2 650 948 cases and 24 464 deaths [6]. In Senegal,
the first case of COVID-19 was detected on 2 March 2020. As
of 5 February 2021, a total of 23 073 confirmed cases and 666
deaths have been reported (http://www.sante.gouv.sn/). Africa
remains less affected by the global pandemic compared to the
rest of the world. However, new variants of SARS-CoV-2, such
as British variant B.1.1.7, South African variant B.1.351 and
Brazilian variant P.1, have been reported [7]. This emergence of
new variants appears to be proportional to the increase in the
number of new cases worldwide [8]. In West Africa, particu-
larly Senegal and the Gambia, a new variant of SARS-CoV-2
called Marseille-1 has also been reported [9]. Recently, vac-
cines such as the Pfizer/BioNTech and Moderna have shown
good efficacy against the B.1.1.7 variant but less effectiveness
against the B.1.351 variant [10].
This study was approved by the National Ethics Committee
for Health Research of Senegal (approval 000159/MSAS/
CNERS/Sec, 21 August 2020). Free and informed consent wasThis is an open access artiprovided by each adult individual who participated in this
study.
In Senegal, the Institut de Recherche en Santé, de Surveil-
lance Epidémiologique et de Formations (IRESSEF), collabo-
rated with the Medical Research Council Unit The Gambia at
London School of Hygiene and Tropical Medicine (MRCG at
LSHTM) to sequence SARS-CoV-2 virus samples and charac-
terize circulating variants within genomes. One hundred naso-
pharyngeal samples were collected in the Thiès region and at
Blaise Diagne International Airport in Senegal. SARS-CoV-2 was
confirmed using PCR at the IRESSEF laboratory. RNA was
extracted and transported to the MRCG at LSHTM for
sequencing. Twenty-four barcode libraries were sequenced on
a flow cell using GridION (Nanopore technology) with ex-
pected coverage of >100× following version 3 of the ARTIC
protocol [11]. The sequences were analysed using the bio-
informatic pipeline from the ARTIC Network (https://artic.
network/ncov-2019). The Pangolin software package (https://New Microbe and New Infect 2021; 41: 100877
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FIG. 2. Phylogenetic tree showing Senegal’s new variant clustering with 201/50Y.V1 variant.
2 New Microbes and New Infections, Volume 41 Number C, May 2021 NMNIgithub.com/cov-lineages/pangolin) was used to assign the lineage
to each genomic sequence of studied samples. Mutation analysis
was performed using the GISAID mutation analysis tool. All the
consensus genome sequences have been deposited in the
GISAID database (https://www.gisaid.org/).
Eighty-three of 100 samples were sequenced successfully.
There were 51 samples (61%) that belonged to the B.1 lineage,
of which only one corresponded to the B.1.1.7 variant (e.g. the
UK variant). This B.1.1.7 variant was isolated from a sample
collected from a 23-year-old woman. The patient tested posi-
tive on 30 December 2020. She arrived in Senegal from India on
14 August 2020 with a negative PCR test for SARS-CoV-2. She
had not traveled since her arrival in Senegal and was only in
contact with her husband and her maid. The rest of the samples
were distributed as follows: B.1.129 (n = 13), B.1.256 (n = 7),
B.1.416 (n = 5), A.19 (n = 1), B.1.1.154 (n = 1), B.1.1.177
(n = 1), B.1.1.292 (n = 1), B.1.1.31 (n = 1), B.1.1.7 (n = 1) and
B.1.258 (n = 1) (Fig. 1). Mutation analysis of the B.1.1.7 variant
revealed the presence of five mutations (N501Y, D614G,
P681H, S982A and D1118H) on the spike glycoprotein. Our
genomic sequences were compared to those of the GISAID
database, and we constructed a phylogenetic tree to highlight
the relationship of Senegal’s strains with other strains in the
world (Fig. 2).© 2021 The Author(s). Published by Elsevier Ltd, NMNI, 41, 100877
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/liceIn conclusion, variant B.1.1.7, termed the ‘UK variant’,
‘British variant’ or ‘English variant’, was detected for the first
time in Senegal in an Indian woman. The emergence of new
SARS-CoV-2 variants throughout the world should lead health
authorities to rely on next-generation sequencing tools to
monitor and control the strains circulating in Senegal.Conflict of interestNone declared.References[1] Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features
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